Genvec News
Most Popular Genvec Story
GenVec shares implode on pancreatic cancer trial failure
GenVec is reeling after its lead therapy TNFerade flunked a Phase III trial for pancreatic cancer. An interim analysis found that the gene therapy was unlikely to prove effective, causing the Read more...
Latest Headlines
- August 6, 2010
- May 14, 2010
- March 29, 2010
- January 19, 2010
- November 5, 2009
- November 4, 2009
- January 30, 2009
- December 18, 2006
- October 10, 2006
- August 22, 2006
- August 15, 2006
- February 14, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
